Wesley Kaupinen compensation by year
PALVELLA THERAPEUTICS Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $375,462 | $384,923 | $575,000 |
| Bonus | $0 | $515,500 | $0 |
| Stock awards | $0 | $0 | $0 |
| Option awards | $209,858 | $4,534,999 | $2,469,886 |
| Non-equity incentive | $0 | $0 | $359,375 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $643 | $643 | $643 |
| Total | $585,963 | $5,436,064 | $3,404,904 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PALVELLA THERAPEUTICS, INC. DEF 14A filed April 30, 2026, accession 0001104659-26-052875, and prior-year filings.
How this page was built: the PALVELLA THERAPEUTICS, INC. filed document, accession 0001104659-26-052875. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 193,033 | — | $14.76 |
| Option | 313,355 | — | $13.60 |
| Option | 6,252 | — | $9.79 |
| Option | 45,821 | — | $7.53 |
Per the Outstanding Equity Awards at Fiscal Year-End table in PALVELLA THERAPEUTICS, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
PALVELLA THERAPEUTICS’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Wesley Kaupinen · this page | President and Chief Executive Officer | $3,404,904 |
| Kathleen Goin | Chief Operating Officer | $1,979,837 |
| Matthew Korenberg | Chief Financial Officer | $1,971,437 |
Board service
PALVELLA THERAPEUTICS board · FY2024–FY2025How this board is paid
Company policy: PALVELLA THERAPEUTICS pays directors a $40,000 cash retainer. As stated in PALVELLA THERAPEUTICS's FY2025 proxy.
Committees
NCGC
The full PALVELLA THERAPEUTICS compensation record
free company briefThis page is one person within PALVELLA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order PALVELLA THERAPEUTICS's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PALVELLA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.